Andrew Sikora is associate professor of Otolaryngology and Vice Chair for Research, Carolyn Wiess Law Research Scholar, and Co-Director of the Head and Neck Cancer Program at the Baylor College of Medicine in Houston, Texas. Dr. Sikora’s research interests include understanding and reversing mechanisms of tumor-mediated immunosuppression, and the immunobiology of HPV-related head and neck cancer. He is the principle investigator of observational and therapeutic clinical trials designed to understand the impact of standard-of-care therapies on anti-tumor immunity, and to test novel immune-based therapies in head and neck cancer. As a nationally-recognized expert in cancer immunotherapy and clinical research, Dr. Sikora is a member of the US National Cancer Institute (NCI) Head and Neck Cancer Steering Committee, the NRG Oncology cooperative group Head and Neck Cancer Core Committee, and frequently serves on US National Institutes of Health (NIH) grant review panels.
At the completion of this educational session, learners will:
- Understand the role(s) of immunotherapy in treatment of HPV/HIV co-infected patients with cancer.
- Appreciate the impacts of standard-of-care treatments on immune function and anti-tumor immunity.
- Be aware of several modern approaches to cancer immunotherapy, including vaccination against tumor-associated antigens and immune checkpoint blockade.
This CME activity was approved for
AMA PRA Category 1 Credit™ on October 18, 2016 and will terminate October 17, 2019.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Sikora (Presenter) had the following personal financial relationships in the prior 12 months with manufactures of the products or services that may be presented in this CME activity: Research grant from Advaxis. Dr. Sikora submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the
PRN Video Channel at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
